Brain Treatment Center

Name

Brain Treatment Center

Website

https://braintreatmentcenterflomo.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Neurological and Mental Health Treatment Services

NAICS

Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Diagnostic Imaging Centers (621512), Services for the Elderly and Persons with Disabilities (624120)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK)

akta.pro secondary industries

Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC), Pediatric Physical Therapy & Developmental Rehab (HSADAIAE)

Keywords

• Neuromodulation therapy
• Brain mapping services
• Autism treatment
• Transcranial magnetic stimulation
• Neurological treatment services

Headquarters

HQ city

Flower Mound

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical Treatment Services: The center generates revenue through providing MeRT therapy and neurological treatment services to patients with autism, depression, anxiety, PTSD, and traumatic brain injury. Treatment is delivered on a per-visit or per-program basis as a healthcare service provider.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Brain Treatment Center delivers MeRT (Magnetic e-Resonance Therapy), a non-invasive neuromodulation service that uses quantitative EEG brain mapping to guide individualized magnetic stimulation protocols for each patient. The center applies this approach to treat pediatric autism as well as adult conditions such as depression, anxiety, PTSD, and traumatic brain injury. Treatment plans are customized per patient and delivered on a per-visit or per-program basis at its clinical site.

Product overview

Brain Treatment Center offers MeRT (Magnetic e-Resonance Therapy) as its primary treatment approach, a data-driven, noninvasive neuromodulation service that combines quantitative EEG brain mapping with individualized magnetic stimulation. The center applies this methodology across multiple neurological conditions including autism spectrum disorder, depression, anxiety, PTSD, and traumatic brain injury. Treatment protocols are customized for each patient based on brain mapping data, with the center also incorporating EEG-guided rTMS (repetitive transcranial magnetic stimulation) techniques as part of its autism research program.

Differentiator

Problem solved

Functional benefit

Products and services

• MeRT (Magnetic e-Resonance Therapy) A non-invasive neuromodulation treatment that uses quantitative EEG brain mapping to guide individualized magnetic stimulation, tailored for each patient to improve communication, attention, and overall quality of life for children with autism and other neurological conditions, including depression, anxiety, PTSD, and traumatic brain injury in adults.

Quantifiable outcome

• Discernible improvements in stereotyped behavior, repetitive behavior, and verbal social domains following TMS intervention (based on 2024 systematic review of studies 2018-2023)

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves3 records

Expansion highlights2 records

Direct peers

• Amen Clinics: Amen Clinics operates a multi-site brain treatment network using SPECT imaging and personalized protocols to address conditions including autism, TBI, PTSD, and depression. It is highly comparable in its brain-mapping-driven, individualized treatment philosophy targeting overlapping patient populations.
• Mindful Health Solutions: Mindful Health Solutions is a multi-site TMS and interventional psychiatry provider serving California and surrounding states. It is comparable in modality and customer segment (adult mental health) but operates at significantly greater scale.
• Achieve TMS: Achieve TMS runs a regional chain of TMS clinics offering protocols for depression, anxiety, PTSD, and other conditions. It competes for the same adult mental-health patient pool that Brain Treatment Center serves alongside its pediatric autism focus.
• Greenbrook TMS: Greenbrook operates a large U.S. network of outpatient TMS treatment centers targeting depression, anxiety, and OCD. It is a direct service-line competitor with similar neuromodulation equipment and a multi-site operating model that contrasts with Brain Treatment Center's single-clinic footprint.
• Neuronetics: Neuronetics manufactures and supports NeuroStar TMS systems used widely in depression treatment and is increasingly referenced in autism/TBI research. Brain Treatment Center relies on the same underlying rTMS modality, making Neuronetics the closest technology peer in the neuromodulation stack.
• Cortica: Cortica runs a multi-site network delivering integrated medical, behavioral, and developmental therapies for children with autism. It competes for the same pediatric autism families that constitute Brain Treatment Center's primary segment, though via a different therapeutic mix.
• Center for Autism and Related Disorders (CARD): CARD is one of the largest U.S. providers of applied behavior analysis (ABA) and related autism therapies. While its modality is different, it targets the same pediatric autism demand pool and competes for parent-pay healthcare dollars in the same household budgets.

Broad incumbents

• Brainsway: Brainsway develops and markets Deep TMS systems, an alternative rTMS platform approved for depression, OCD, and smoking cessation and increasingly studied in autism. As a device incumbent, it represents both a technology alternative and a potential partner for Brain Treatment Center's clinics.
• Magstim: Magstim is a long-standing manufacturer of TMS stimulators widely used in clinical research and depression treatment. As a device incumbent and research-grade supplier, it is comparable on the underlying technology powering Brain Treatment Center's MeRT offering.

Emerging players

• Maple Leaf Neurofeedback: Maple Leaf Neurofeedback is an example of the broader field of EEG-guided neurofeedback and neuromodulation clinics targeting similar conditions (autism, ADHD, TBI). It represents the wider ecosystem of smaller specialty clinics that Brain Treatment Center could acquire, partner with, or compete against as it scales.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brain Treatment Center